AlphAIAlphAI — Financial news for AI agents
SEC EDGAR 8-KSEP 141 min read$CW

CURTISS WRIGHT CORP (CW): Other Events

CURTISS WRIGHT CORP (CW) filed an SEC Form 8-K — Other Events. NEWS RELEASE FOR IMMEDIATE RELEASE Contact: Jim Ryan (704) 869-4621 jim.ryan@curtisswright.com CURTISS-WRIGHT RAISES TOTAL SHARE REPURCHASE AUTHORIZATION TO $700 MILLION AND ANNOUNCES AN ADDITIONAL $100 MILLION EXPANSION OF 2026 SHARE REPURCHASE PROGRAM Declares Quarterly Dividen

Original reporting
SEC EDGAR 8-K
Published Sep 14, 2026, 5:17 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 21, 2026, 11:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefCorporate actions
Primary signal
$CW
Bullish
medium confidence
Mentioned
$CW
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CWBullishMed
01

Why it matters

The new authorization reflects management confidence and could provide short‑term price support, but the long‑term effect depends on earnings performance.

02

Market read

The announcement adds a material buyback tranche, likely influencing CW's stock and peers in the sector.

03

What to watch

Future cash flow constraints if earnings miss expectations could limit execution of the program.

Relevance 6/10Novelty 7/10Timing: immediate

Background

Curtiss‑Wright Corp (NYSE: CW) filed an 8‑K reporting an expanded share repurchase program and a quarterly dividend.

Company-level read

Ticker impact

$CWBullishMedium confidence
Context

Curtiss‑Wright announced an additional $100 million share repurchase tranche, raising total authorization to $700 million and declaring a $0.26 quarterly dividend.

Expected impact

Potential modest upside as the market absorbs the new repurchase capacity.

Evidence & confidence

A $100 M tranche is sizable for a mid‑cap and indicates strong balance‑sheet health, but the impact is likely limited to short‑term price support.

Market effects

Sector

Buyback signals confidence in aerospace & defense sector, may lift peer sentiment.

Regional

US market, modest effect on industrial stocks.

Global

Limited to investors tracking US mid‑cap industrials.

Counterpoint

What could challenge this read

The repurchase may be a defensive move masking slower organic growth.

Key entities

  • company
    Curtiss‑Wright Corp

    Industrial aerospace & defense manufacturer.

  • executive
    Lynn M. Bamford

    Chair and CEO of Curtiss‑Wright.

Read at source← All news

Related articles

SEP 22
$CWMedAI 8/10

Why is Curtiss-Wright stock sliding today?

Curtiss-Wright stock fell 4.0% after announcing CEO Lynn M. Bamford will transition to Executive Chair, with COO Kevin M. Rayment succeeding in 2027. The change introduced strategic uncertainty, and the stock is near a 52-week low of $544.64, below its high of $808.16. The ex-dividend date is also approaching, adding to the pressure.

investing.com2 min
SEP 15
$CWMed

CW Initiated Coverage by Guggenheim -- Rating Upgraded to Buy

Guggenheim initiated coverage on Curtiss-Wright (CW) with a 'Buy' rating and a $786.00 price target. The stock is currently trading at $551.21, which is 24.3% above its GF Value™ of $443.58, indicating overvaluation. CW has a GF Score™ of 94/100, reflecting strong performance in growth and profitability, but a valuation rank of 5/10. Insider activity shows net selling of $705,928 over the last three months.

gurufocus.com2 min
SEP 6
$CWMed

Curtiss Wright (CW) Wins New Defense Work, Is The Stock Cheap After The Selloff?

Curtiss-Wright (CW) secured $40M in contracts for the U.S. Army's air defense system. Its stock is down 24.3% over 30 days, but up 17.8% over 1 year. Analysts debate its valuation, with some seeing it as undervalued at $566.75, citing strong backlog growth and growth projections. The company trades at a P/E of 38.7x, lower than peers but higher than its own fair ratio of 24.8x.

simplywall.st3 min
SEP 2
$CWMed

Piper Sandler initiates Curtiss-Wright stock at neutral on valuation

Piper Sandler initiated coverage on Curtiss-Wright (NYSE:CW) with a Neutral rating and $665 price target, citing valuation concerns. The company reported Q2 earnings beating EPS estimates but missing on revenue. Curtiss-Wright's order book is up 12% YTD, and it raised its full-year outlook. Piper Sandler notes the stock's multiple expansion and potential overvaluation.

investing.com2 min
SEP 1
$CWHighAI 8/10

Curtiss-Wright reports strong Q2 2026 results and raises full-year guidance across defense, nuclear and industrial markets

Curtiss-Wright reported Q2 2026 sales of $924M, adjusted EPS of $3.72, and adjusted operating margin of 19.4%, all above expectations. The company raised full-year guidance to 8-9% sales growth and 14-16% EPS growth, with free cash flow outlook at $585M-$605M. New orders increased 8% YoY to $1.1B, and backlog reached $4.5B, up 10% from year-end 2025.

bicmagazine.com1 min